Basic Information
Pregabalin Accord
Regulatory Information
EMEA/H/C/004024
August 28, 2015
June 25, 2015
19
January 27, 2025
Company Information
Spain
Edificio Este Planta 6a World Trade Center Moll De Barcelona S/n 08039 Barcelona
ACCORD HEALTHCARE SL
Drug Classification
Active Substances Detail
EMA Resources
Detailed Information
Therapeutic Indication
### Therapeutic indication Epilepsy - Pregabalin Accord is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. Generalised Anxiety Disorder - Pregabalin Accord is indicated for the treatment of Generalised Anxiety Disorder (GAD) in adults.
Overview Summary
This is a summary of the European public assessment report (EPAR) for Pregabalin Accord. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Pregabalin Accord. For practical information about using Pregabalin Accord, patients should read the package leaflet or contact their doctor or pharmacist.